You can buy or sell BioVie and other stocks, options, and ETFs commission-free!
BioVie Inc. Class A Common Stock, also called BioVie, is a development stage biopharmaceutical company, which discovers, develops, and commercializes drug therapies for liver disease. Read More It focuses on BIV201 which treats ascites due to chronic liver cirrhosis. The company was founded on April 10, 2013 and is headquartered in Santa Monica, CA. The listed name for BIVI is BioVie Inc. Class A Common Stock.
Santa Monica, California
52 Week High
52 Week Low
— per share